{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T01:15:31Z","timestamp":1759540531054,"version":"build-2065373602"},"reference-count":42,"publisher":"Wiley","issue":"1","content-domain":{"domain":["wiley.com","cochranelibrary.com"],"crossmark-restriction":true},"short-container-title":[],"DOI":"10.1002\/14651858.cd003672","type":"journal-article","created":{"date-parts":[[2003,11,21]],"date-time":"2003-11-21T17:14:00Z","timestamp":1069434840000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Cholinesterase inhibitors for dementia with Lewy bodies"],"prefix":"10.1002","volume":"2010","author":[{"given":"Rebecca","family":"Wild","sequence":"first","affiliation":[{"name":"Royal Bolton Infirmary; Belmont Day Hospital; Minnerva Road Bolton UK BL4 7AA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tor ACL","family":"Pettit","sequence":"additional","affiliation":[{"name":"Cheadle Royal Hospital; 100 Wilmslow Road Cheadle Cheshire UK SK8 3DG"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Burns","sequence":"additional","affiliation":[{"name":"University of Manchester; Psychiatric Research Group; 3rd Floor University Place Manchester UK M13 9PL"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2003,7,21]]},"reference":[{"key":"10.1002\/14651858.CD003672-BIB0001|cit1","unstructured":"Byrne J Treatment of Lewy body dementia with Exelon National Research Register 2000 http:\/\/www.update-software.com\/NRR"},{"key":"10.1002\/14651858.CD003672-BIB0003|cit2","unstructured":"Del Ser T Efficacy of cholinesterase inhibitors in lewy body dementia Sixth International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy; April 5-8, 2000; Stockholm, Sweden 2000 51"},{"issue":"11","key":"10.1002\/14651858.CD003672-BIB0002|cit3","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5","article-title":"Dementia with Lewy bodies: findings from an international multicentre study","volume":"15","author":"Ser","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/14651858.CD003672-BIB0004|cit4","unstructured":"McKeith I Del Ser T Anand R Rivastigmine provides symptomatic benefit in dementia with lewy bodies: findings from a placebo-controlled international multicenter study Neurology 2000e A450"},{"key":"10.1002\/14651858.CD003672-BIB0005|cit5","doi-asserted-by":"crossref","unstructured":"McKeith I Del Ser T Spano P Emre M Wesnes K Anand R Cicin-Sain A Ferrara R Spiegel R Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study Lancet 2000f 2031 6","DOI":"10.1016\/S0140-6736(00)03399-7"},{"key":"10.1002\/14651858.CD003672-BIB0006|cit6","unstructured":"Rossor MN A prospective, multicentre, randomised double blind placebo controlled exploratory study to evaluate the safety, tolerability and efficacy of a new drug in patients suffering from probable dementia with Lewy bodies National Research Register http:\/\/www.update-software.com\/NRR 1999"},{"issue":"3","key":"10.1002\/14651858.CD003672-BIB0007|cit7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1159\/000048651","article-title":"Effects of rivastigmine on cognitive function in dementia with lewy bodies: A randomised placebo controlled international study using the Cognitive Drug Research Computerised Assessment system.","volume":"13","author":"Wesnes","year":"2002","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1002\/14651858.CD003672-BIB0008|cit8","unstructured":"Anand R Enz A Novartis Pharmaceuticals Corporation Effects of rivastigmine extend beyond symptomatic treatment in patients with alzheimer 's disease(AD): new clinical studies Sixth International Stockholm\/Springfield Symposium on Advances in Alzheimer Therapy; April 5-8, 2000; Stockholm, Sweden 2000 29"},{"key":"10.1002\/14651858.CD003672-BIB0009|cit9","doi-asserted-by":"crossref","unstructured":"McKeith IG Grace JB Walker Z Byrne EJ Wilkinson D Stevens T Perry EK Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial Int-J-Geriatr-Psychiatry 2000d 387 92","DOI":"10.1002\/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9"},{"key":"10.1002\/14651858.CD003672-BIB0010|cit10","unstructured":"McKeith IG A pilot study into the effects of donepezil on cognitive impairment and neuropsychiatric features in patients with dementia with Lewy bodies and Parkinson's disease National Research Register 2000g http:\/\/www.doh.gov.uk\/nrr.htm"},{"key":"10.1002\/14651858.CD003672-BIB0011|cit11","doi-asserted-by":"crossref","unstructured":"Samuel W Caligiuri M Galasko D Lacro J Marini M McClure FS Warren K Jeste DV Better cognitive and psychopathologic response to donepezil in patients prospectively diagnosed as dementia with Lewy bodies: A preliminary study International Journal of Geriatric Psychiatry 2000 794 802","DOI":"10.1002\/1099-1166(200009)15:9<794::AID-GPS178>3.0.CO;2-1"},{"key":"10.1002\/14651858.CD003672-BIB0012|cit12","unstructured":"Walker Z Lewy body dementia: The investigation of pre and post synaptic dopaminergic receptors with SPET NRR 2000 http:\/\/www.doh.gov.uk\/nrr.htm"},{"key":"10.1002\/14651858.CD003672-BIB0013|cit13","unstructured":"Wilcock GK A double-blind, placebo-controlled, randomised, parallel group phase IIa study of the efficacy and safety of a novel therapy in the treatment of behavioural and psychological symptoms in subjects with dementia with Lewy bodies National Research Register 2000e"},{"key":"10.1002\/14651858.CD003672-BIB0014|cit14","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1002\/gps.930080707","article-title":"Idiopathic clouding of consciousness - do patients have cortical Lewy Body Disease?","volume":"8","author":"Ballard","year":"1995","journal-title":"Int J Geriatr Psychiat"},{"issue":"4","key":"10.1002\/14651858.CD003672-BIB0015|cit15","article-title":"Rivastigmine for Alzheimer's disease","author":"Birks","year":"2001","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"1","key":"10.1002\/14651858.CD003672-BIB0016|cit16","article-title":"Donepezil for dementia due to Alzheimer's disease","author":"Birks","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1002\/14651858.CD003672-BIB0017|cit17","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1056\/NEJM198312013092204","article-title":"Bias in treatment assignment in controlled clinical trials","volume":"309","author":"Chalmers","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1002\/14651858.CD003672-BIB0018|cit18","volume-title":"Cochrane Reviewers Handbook 4.1.2 [updated March 2001]","volume":"issue 2","author":"Clarke","year":"2001"},{"key":"10.1002\/14651858.CD003672-BIB0019|cit19","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.1212\/WNL.44.12.2308","article-title":"The neuropsychiatric inventory: Comprehensive assessment of psychopathology in dementia","volume":"44","author":"Cummings","year":"1994","journal-title":"Neurology"},{"issue":"11","key":"10.1002\/14651858.CD003672-BIB0020|cit20","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1002\/1099-1166(200011)15:11<1034::AID-GPS231>3.0.CO;2-5","article-title":"Dementia with Lewy bodies: findings from an international multicentre study","volume":"15","author":"Ser","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/14651858.CD003672-BIB0021|cit21","first-page":"153","article-title":"Members of the UPDRS development committe: Unified Parkinson's Disease Rating Scale","volume-title":"Recent Developments in Parkinson's Disease","author":"Fahn","year":"1987"},{"key":"10.1002\/14651858.CD003672-BIB0022|cit22","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0022-3956(75)90026-6","article-title":"\"Mini-mental state\": A practical method for grading the cognitive state of patients for the clinician","volume":"12","author":"Folstein","year":"1975","journal-title":"J Psychiatr Res"},{"volume-title":"ECDEU Assessment manual for psychopharmacology","year":"1976","author":"Guy","key":"10.1002\/14651858.CD003672-BIB0023|cit23"},{"key":"10.1002\/14651858.CD003672-BIB0024|cit24","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1192\/bjp.174.1.45","article-title":"Validity of current clinical criteria for Alzheimer's disease, vascular dementia and dementia with Lewy bodies","volume":"174","author":"Holmes","year":"1999","journal-title":"Br J Psychiatry"},{"key":"10.1002\/14651858.CD003672-BIB0025|cit25","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2307\/2530041","article-title":"A review of some statistical methods for covariance analysis of categorical data","volume":"38","author":"Koch","year":"1982","journal-title":"Biometrics"},{"issue":"5","key":"10.1002\/14651858.CD003672-BIB0026|cit26","first-page":"185","article-title":"Diffuse type of Lewy body disease: progressive dementia with abundant cortical Lewy bodies and senile changes of varying degree - a new disease?","volume":"3","author":"Kosaka","year":"1984","journal-title":"Clin Neuropathol"},{"issue":"10","key":"10.1002\/14651858.CD003672-BIB0027|cit27","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1212\/WNL.43.10.1927","article-title":"Neurotransmitters in basal ganglia and cortex of Alzheimer's disease with and without Lewy bodies","volume":"43","author":"Langlais","year":"1993","journal-title":"Neurology"},{"issue":"1","key":"10.1002\/14651858.CD003672-BIB0028|cit28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1002\/ana.410350113","article-title":"Alzheimer's disease and Lewy body disease: a comparative clinicopathological study","volume":"35","author":"Lippa","year":"1994","journal-title":"Ann Neurol"},{"issue":"1","key":"10.1002\/14651858.CD003672-BIB0029|cit29","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1002\/ana.410430117","article-title":"The medial temporal lobe in dementia with Lewy bodies: a comparative study with Alzheimer's disease","volume":"43","author":"Lippa","year":"1998","journal-title":"Ann Neurol"},{"issue":"7","key":"10.1002\/14651858.CD003672-BIB0030|cit30","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1002\/(SICI)1099-1166(199907)14:7<526::AID-GPS965>3.0.CO;2-0","article-title":"Sensitivity and specificity of three clinical criteria for dementia with Lewy bodies in an autopsy-verified sample","volume":"14","author":"Luis","year":"1999","journal-title":"Int J Geriatr Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003672-BIB0031|cit31","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1002\/(SICI)1099-1166(200005)15:5<387::AID-GPS131>3.0.CO;2-9","article-title":"Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial","volume":"15","author":"McKeith","year":"2000","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1002\/14651858.CD003672-BIB0032|cit32","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/S0140-6736(98)01085-X","article-title":"Does quality of reports of randomized trials affect estimates of intervention efficacy reported in meta-analyses?","volume":"352","author":"Moher","year":"1998","journal-title":"Lancet"},{"key":"10.1002\/14651858.CD003672-BIB0033|cit33","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(00)03589-3","article-title":"Pathological correlates of late-onset dementia in a multicentre, community-based population in England and Wales","volume":"357","author":"Neuropathology Group of the Medical Research Council cognitive function and Ageing Study (MRC CFAS)","year":"2001","journal-title":"Lancet"},{"issue":"1","key":"10.1002\/14651858.CD003672-BIB0034|cit34","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD001747.pub3","article-title":"Galantamine for Alzheimer's disease and mild cognitive impairment","author":"Loy","year":"2006","journal-title":"Cochrane Database of Systematic Reviews"},{"issue":"7","key":"10.1002\/14651858.CD003672-BIB0035|cit35","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/00001756-199403000-00002","article-title":"Neocortical cholinergic activities differentiate Lewy body dementia from classical Alzheimer's disease","volume":"5","author":"Perry","year":"1994","journal-title":"Neuroreport"},{"issue":"6","key":"10.1002\/14651858.CD003672-BIB0036|cit36","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1136\/jnnp.74.6.720","article-title":"Dementia with Lewy bodies according to the consensus criteria in a general population aged 75 years or older","volume":"74","author":"Rahkonen","year":"2003","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"5","key":"10.1002\/14651858.CD003672-BIB0037|cit37","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/00005072-199705000-00006","article-title":"Dementia with Lewy bodies versus pure Alzheimer disease: differences in cognition, neuropathology, cholinergic dysfunction, and synapse density","volume":"56","author":"Samuel","year":"1997","journal-title":"J Neuropathol Exp Neurol"},{"issue":"3","key":"10.1002\/14651858.CD003672-BIB0038|cit38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1017\/S1041610298005341","article-title":"Donepezil for treatment of dementia with Lewy bodies: a case series of nine patients","volume":"10","author":"Shea","year":"1998","journal-title":"Int Psychogeriatr"},{"key":"10.1002\/14651858.CD003672-BIB0039|cit39","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/gps.930091107","article-title":"What is the clinical prevalence of Lewy Body Dementia?","volume":"9","author":"Shergill","year":"1994","journal-title":"Int J Geriatr Psychiat"},{"key":"10.1002\/14651858.CD003672-BIB0040|cit40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias","volume":"273","author":"Shulz","year":"1995","journal-title":"JAMA"},{"issue":"1","key":"10.1002\/14651858.CD003672-BIB0041|cit41","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/BF00313493","article-title":"Cortical changes in the parkinsonian brain: a contribution to the delineation of \"diffuse Lewy body disease\"","volume":"229","author":"Yoshimura","year":"1983","journal-title":"J Neurol"},{"issue":"3","key":"10.1002\/14651858.CD003672-BIB0042|cit42","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD003672","article-title":"Cholinesterase inhibitors for dementia with Lewy bodies","author":"Wild","year":"2003","journal-title":"Cochrane Database of Systematic Reviews"}],"container-title":["Cochrane Database of Systematic Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1002\/14651858.CD003672\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,3]],"date-time":"2025-10-03T22:04:27Z","timestamp":1759529067000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1002\/14651858.CD003672"}},"subtitle":[],"editor":[{"name":"Cochrane Dementia and Cognitive Improvement Group","sequence":"additional","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2003,7,21]]},"references-count":42,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2010,1]]}},"URL":"https:\/\/doi.org\/10.1002\/14651858.cd003672","relation":{},"ISSN":["1465-1858"],"issn-type":[{"type":"electronic","value":"1465-1858"}],"subject":[],"published":{"date-parts":[[2003,7,21]]}}}